Track Apollo Hospitals live share price with 52 week high and low, chart views, fundamentals, financial highlights, ratios, peer comparison, dividends, bonuses/splits and company details. This page is educational and does not provide buy or sell recommendations.
Switch between 1 Day, 5 Day, 1 Month and 1 Year chart views. Prices are from the latest available Yahoo Finance-compatible market feed.
Live market fields may be delayed or temporarily unavailable. Verify the latest price, valuation ratios and 52 week range from NSE, BSE or your broker before making financial decisions.
Apollo Hospitals Enterprise Ltd is a listed Indian healthcare company headquartered in Chennai. It operates a broad healthcare ecosystem covering multi-speciality hospitals, advanced clinical care, pharmacies, diagnostics, preventive health checks and digital health services.
For customers, Apollo Hospitals is mainly relevant for doctor consultations, inpatient care, surgeries, emergency treatment, health checkups, pharmacy services and connected digital healthcare through Apollo 24|7. Services, doctors, pricing and insurance support can differ by hospital and city, so patients should verify details through official channels before booking.
For investors, the key monitorables include revenue growth, hospital occupancy, average revenue per occupied bed, bed additions, specialty mix, pharmacy and digital health profitability, diagnostics growth, debt, cash flow, return ratios and valuation multiples.
Apollo Hospitals is commonly tracked across healthcare services, Apollo HealthCo / pharmacy and digital health, diagnostics, clinics and retail health. Investors often compare it with listed healthcare peers such as Max Healthcare, Fortis Healthcare, Narayana Hrudayalaya, Aster DM Healthcare and Global Health.
Apollo Hospitals earns money from hospital care, surgeries, inpatient and outpatient services, diagnostics, preventive health checks, pharmacy distribution, digital consultations and related healthcare services. The hospital business is influenced by occupancy, bed capacity, specialty procedures, doctor availability, payer mix and average revenue per occupied bed.
The wider ecosystem includes Apollo 24|7, pharmacies, diagnostics, clinics and connected care services. These platforms can improve customer access and cross-sell, but investors should also monitor margins, cash burn, restructuring updates and regulatory changes in healthcare and pharmacy businesses.
Important drivers of the business model include patient volumes, complex procedure mix, new bed additions, asset utilisation, medical talent retention, insurance relationships, pharmacy scale, digital health unit economics, operating leverage and free cash flow after capital expenditure.
Educational note: financial, segment, dividend, bonus, split and shareholding details should be verified from the latest annual report, investor presentation, NSE filings and BSE filings before making any financial decision.
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue from Operations | ₹19,059 Cr | ₹21,794 Cr | ₹25,229 Cr |
| EBITDA | ₹2,390 Cr | ₹3,022 Cr | ₹3,769 Cr |
| EBITDA Margin | 12.5% | 13.9% | 14.9% |
| Profit After Tax | ₹900 Cr | ₹1,446 Cr | ₹1,942 Cr |
| Net Profit Margin | 4.7% | 6.6% | 7.7% |
| Financial Statement Note | Verify annual report | Verify annual report | Verify exchange filings |
The financial highlights are meant for education and should be checked against the latest audited financial statements and exchange filings.
| Balance Sheet Area | What Beginners Should Track | Why It Matters |
|---|---|---|
| Net Worth / Equity | Retained profits, reserves and shareholder capital | A growing equity base can support future hospitals, diagnostics and digital health investments. |
| Borrowings and Lease Liabilities | Debt, finance cost and repayment schedule | Hospital expansion is capital intensive, so investors should watch leverage and interest coverage. |
| Fixed Assets and Right-of-Use Assets | Hospitals, medical equipment, buildings and leased facilities | These assets show capacity creation but also require high utilisation to earn returns. |
| Cash and Investments | Liquidity available for operations, capex and acquisitions | Strong liquidity helps manage expansion, working capital and unexpected healthcare demand cycles. |
| Working Capital | Receivables, payables, inventories and pharmacy working capital | Changes here can affect operating cash flow even when reported profit is growing. |
| Latest Filing Check | Use annual report and exchange filings | Balance sheet numbers should be verified from official NSE, BSE and company disclosures. |
Use the latest annual report and quarterly results to verify exact balance sheet numbers, debt, leases, cash and capital expenditure.
| Cash Flow / Segment Highlight | Investor Interpretation | Monitorable |
|---|---|---|
| Operating Cash Flow | Cash generated from hospitals, pharmacy, diagnostics and healthcare services after working capital movement. | Compare with profit after tax to understand quality of earnings. |
| Capital Expenditure | Spending on new hospitals, beds, medical equipment, technology and maintenance. | High capex can create future growth but may reduce free cash flow in the near term. |
| Healthcare Services | Core hospitals and clinical services are key margin and brand drivers. | Watch occupancy, average revenue per occupied bed, specialty mix and bed additions. |
| Apollo HealthCo / Digital and Pharmacy | Digital health, pharmacy distribution and online healthcare services can support customer reach. | Watch revenue growth, unit economics, losses, cash burn and restructuring updates. |
| Diagnostics and Retail Health | Clinics, diagnostics, preventive health checks and connected care support the wider Apollo ecosystem. | Watch network expansion, test volumes, margins and return on capital. |
| Latest Filing Check | Use official annual results, investor presentations and exchange filings. | Segment and cash flow details can change after restructuring or new disclosures. |
Cash flow and segment performance can change with acquisitions, restructuring and capex. Verify the latest company disclosures.
| Metric | Recent Snapshot | How to Use It |
|---|---|---|
| Revenue Growth | FY25: 14% | FY26: 16% |
| EBITDA Growth | FY25: 26% | FY26: 25% |
| PAT Growth | FY25: 61% | FY26: 34% |
| EBITDA Margin | FY25: 13.9% | FY26: 14.9% |
| Dividend Yield | Use live feed / filings | Verify record date and amount |
| Valuation Ratios | P/E and P/B update with market price | Use live feed plus official financials |
Valuation ratios move daily with share price. Use live market data together with official earnings numbers.
| Company | Business Focus | Ticker | What to Compare | Investor Note |
|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | Hospitals, pharmacy, diagnostics, digital health | APOLLOHOSP | Scale, margins, occupancy, capex and digital health performance | Use as base company for comparison |
| Max Healthcare Institute Ltd | Hospitals and specialty healthcare | MAXHEALTH | Hospital margins, bed expansion, case mix and valuation | Large private hospital peer |
| Fortis Healthcare Ltd | Hospitals and diagnostics exposure | FORTIS | Hospital profitability, diagnostics contribution and governance updates | Comparable healthcare services peer |
| Narayana Hrudayalaya Ltd | Hospitals with focus on affordable specialty care | NH | Occupancy, ARPOB, international business and margins | Useful for hospital operating comparison |
| Aster DM Healthcare Ltd | Hospitals, clinics and pharmacies | ASTERDM | India healthcare growth, margins and restructuring impact | Compare with care delivery network |
| Global Health Ltd | Medanta hospitals and specialty care | MEDANTA | Premium hospital positioning, bed additions and profitability | Relevant listed hospital peer |
| Year | Dividend Detail | Note |
|---|---|---|
| FY 2025-26 | Dividend declared with FY26 results / interim payouts may apply | Verify amount, record date and payment date from NSE, BSE and company filings |
| FY 2024-25 | Dividend history available from exchange/company records | Historical dividend does not guarantee future dividend |
| FY 2023-24 | Dividend history available from exchange/company records | Check official corporate action history before relying on any number |
| Action | Detail | Note |
|---|---|---|
| Bonus Issue | No bonus detail is hard-coded on this page | Verify complete history from official exchange corporate actions |
| Stock Split / Face Value | Use official corporate action and company filings for latest face value | Face value and split history can affect chart interpretation |
| Investor Reminder | Corporate actions can change after board/shareholder approval | Always verify record date, ex-date and entitlement from NSE/BSE filings |
Corporate action reminder: verify dividend amount, ex-date, record date, bonus, split and face value information from official NSE, BSE and company announcements. This page is educational and does not replace exchange filings.
These FAQs help users understand Apollo Hospitals beyond the share price, including healthcare services, appointments, Apollo 24|7, diagnostics, pharmacy, business model, risks, dividends and investor monitorables.
Apollo Hospitals Enterprise Ltd is an Indian healthcare company known for multi-speciality hospitals, advanced clinical care, pharmacies, diagnostics, preventive health checks, digital health services and patient support services. Patients should use official Apollo channels for appointment, doctor, fee, insurance and hospital-specific information.
Patients can generally book appointments through the official Apollo Hospitals website, Apollo 24|7 digital platform, helpline numbers or hospital counters. Before visiting, customers should verify doctor availability, consultation fee, hospital location, insurance acceptance and required medical records.
Apollo Hospitals is commonly associated with cardiology, oncology, neurosciences, orthopaedics, gastroenterology, nephrology, transplants, emergency care, critical care, robotic surgery, diagnostics and preventive healthcare. Availability can differ by city and hospital unit.
Apollo 24|7 is the group digital health platform used for services such as online doctor consultations, pharmacy orders, lab tests and health records. Investors usually track it as part of Apollo’s digital health and pharmacy ecosystem, while customers should verify service coverage and delivery terms in their location.
The company earns revenue from hospital services, surgeries, inpatient and outpatient care, pharmacies, diagnostics, preventive health checks, digital health services and related healthcare offerings. Key business drivers include occupancy, bed capacity, average revenue per occupied bed, specialty mix, pharmacy scale, diagnostics growth and operating margins.
Retail investors track Apollo Hospitals because it is a large listed healthcare company with exposure to hospitals, pharmacy, diagnostics and digital health. Investors usually monitor revenue growth, margins, capacity expansion, occupancy, debt, cash flow, return ratios, regulatory changes and competitive intensity.
Important risks include high capital expenditure for hospital expansion, execution delays, doctor and clinical talent availability, regulatory price controls, insurance and government policy changes, competition, pharmacy and digital health losses, medical liability risk and valuation risk. This page does not provide buy or sell recommendations.
Apollo Hospitals has declared dividends in the past, but dividend amount, record date, payment date and eligibility can change each year. Investors should verify the latest dividend announcements from NSE, BSE and company filings before relying on any historical information.
Corporate actions such as bonus issues, stock splits or face value changes should always be verified from official exchange filings and company announcements. This page provides a monitoring section but should not be treated as the final corporate action record.
Patients should compare doctor experience, department availability, hospital accreditation, estimated treatment cost, insurance coverage, emergency readiness, post-discharge care, distance from home and second-opinion options before making a healthcare decision.
Beginners can start with revenue growth, EBITDA margin, profit after tax, cash flow from operations, debt, capital expenditure, occupancy, bed additions and segment performance. Always compare latest results with official annual reports and exchange filings.
Common listed healthcare peers include Max Healthcare, Fortis Healthcare, Narayana Hrudayalaya, Aster DM Healthcare and Global Health. Peer comparison should consider scale, city mix, margins, growth, debt, occupancy, specialty mix and valuation multiples.
The 52 week high and low change with market data. Use the live quote area of this page for the latest available feed and verify the official exchange quote before making any investment decision.
Suitability depends on the investor’s risk profile, time horizon, valuation comfort and research process. This page is educational and does not make buy, sell or hold recommendations. Investors should consult a SEBI-registered adviser if needed.
